UY32203A - Amino pirimidinas y su uso en terapia - Google Patents
Amino pirimidinas y su uso en terapiaInfo
- Publication number
- UY32203A UY32203A UY0001032203A UY32203A UY32203A UY 32203 A UY32203 A UY 32203A UY 0001032203 A UY0001032203 A UY 0001032203A UY 32203 A UY32203 A UY 32203A UY 32203 A UY32203 A UY 32203A
- Authority
- UY
- Uruguay
- Prior art keywords
- therapy
- pirimidinas
- amino
- processes
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Se proporcionan nuevos derivados de pirimidina de fórmula (I) o sales farmacéuticamente aceptables de los mismos, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08305748 | 2008-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32203A true UY32203A (es) | 2010-05-31 |
Family
ID=41606681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032203A UY32203A (es) | 2008-10-29 | 2009-10-28 | Amino pirimidinas y su uso en terapia |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100105655A1 (es) |
AR (1) | AR074002A1 (es) |
TW (1) | TW201022262A (es) |
UY (1) | UY32203A (es) |
WO (1) | WO2010049731A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY33213A (es) | 2010-02-18 | 2011-09-30 | Almirall Sa | Derivados de pirazol como inhibidores de jak |
TW201219383A (en) * | 2010-08-02 | 2012-05-16 | Astrazeneca Ab | Chemical compounds |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
PT3176170T (pt) | 2012-06-13 | 2019-02-05 | Incyte Holdings Corp | Compostos tricíclicos substituídos como inibidores de fgfr |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
PE20152033A1 (es) | 2013-04-19 | 2016-01-21 | Incyte Holdings Corp | Heterociclos bicicliclos como inhibidores de fgfr |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
EP3617205B1 (en) | 2015-02-20 | 2021-08-04 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
JP6608565B2 (ja) * | 2017-01-26 | 2019-11-20 | ハンミ ファーマシューティカルズ カンパニー リミテッド | ピリミジン化合物及びその医薬用途 |
JP7113528B2 (ja) | 2017-02-01 | 2022-08-05 | オーセントラ セラピュティクス ピーティーワイ エルティーディー | 治療薬としてのN-シクロアルキル/ヘテロシクロアルキル-4-(イミダゾ[1,2-a]ピリジン)ピリミジン-2-アミン誘導体 |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
CN112867716A (zh) | 2018-05-04 | 2021-05-28 | 因赛特公司 | Fgfr抑制剂的固体形式和其制备方法 |
CA3099116A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
CN110563656A (zh) * | 2018-06-06 | 2019-12-13 | 四川大学 | 嘧啶类小分子化合物及在制备抗分枝杆菌药物中的用途 |
US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
WO2020119739A1 (zh) * | 2018-12-12 | 2020-06-18 | 暨南大学 | 2-氨基嘧啶类化合物及其应用 |
WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
WO2020180959A1 (en) | 2019-03-05 | 2020-09-10 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
CN116348458A (zh) | 2019-08-14 | 2023-06-27 | 因赛特公司 | 作为cdk2抑制剂的咪唑基嘧啶基胺化合物 |
US11851426B2 (en) | 2019-10-11 | 2023-12-26 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
JOP20220083A1 (ar) | 2019-10-14 | 2023-01-30 | Incyte Corp | حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
CA3162010A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derivatives of an fgfr inhibitor |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9919778D0 (en) * | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
WO2001060816A1 (en) * | 2000-02-17 | 2001-08-23 | Amgen Inc. | Kinase inhibitors |
WO2002006579A2 (en) * | 2000-07-13 | 2002-01-24 | Auburn University | Biocidal polyamides and methods |
JP4309657B2 (ja) * | 2001-02-20 | 2009-08-05 | アストラゼネカ・アクチエボラーグ | Gsk−3関連障害の治療のための2−アリルアミノ−ピリミジン |
CA2623374A1 (en) * | 2005-09-30 | 2007-04-05 | Astrazeneca Ab | Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
US8680113B2 (en) * | 2008-07-01 | 2014-03-25 | Ptc Therapeutics, Inc. | BMI-1 protein expression modulators |
-
2009
- 2009-10-28 TW TW098136541A patent/TW201022262A/zh unknown
- 2009-10-28 UY UY0001032203A patent/UY32203A/es unknown
- 2009-10-28 US US12/607,505 patent/US20100105655A1/en not_active Abandoned
- 2009-10-28 WO PCT/GB2009/051447 patent/WO2010049731A1/en active Application Filing
- 2009-10-29 AR ARP090104179A patent/AR074002A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20100105655A1 (en) | 2010-04-29 |
WO2010049731A1 (en) | 2010-05-06 |
TW201022262A (en) | 2010-06-16 |
AR074002A1 (es) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
ECSP10010693A (es) | Compuestos pirazólicos 436 | |
NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
UY32351A (es) | Compuestos de pirimidinil indol para uso como inhibidores de atr | |
DOP2010000259A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
NI201000004A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas. | |
ECSP099750A (es) | Imidazoquinolinas con propiedades inmunomoduladoras | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY31456A1 (es) | Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
ECSP10010664A (es) | Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
UY31865A (es) | Derivados de urea heterocíclicos y métodos para la utilización de los mismos | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY32856A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
UY31839A (es) | Compuestos | |
UY32694A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
UY30982A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
CU20100250A7 (es) | Compuestos pirazólicos 436 | |
CU23604B7 (es) | Compuestos terapéuticos | |
CU20100172A7 (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos-211 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20130124 |